Synergy Pharmaceuticals Inc (NASDAQ:SGYP)
Wednesday’s Trading Day
| 5.05 |  +0.09 / +1.81% |
Data as of May 22 | Day’s Change |
Thursday’s Pre-Market Switch to standard view »
| 5.00 |  -0.05 / -0.99% |
Volume: 1.0K |
Latest SGYP News | Press Releases
| Synergy Pharma Posts Wider Loss - Analyst Blog May 15 / Zacks.com |
Today’s Trading
| Previous close | 4.96 |
| Today’s open | 5.00 |
| Day’s range | -- - -- |
| Volume | 1,144,925 |
| Average volume (3 months) | 1,011,676 |
| Market cap | $455.4M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | -113.33% |
| Earnings growth (this year) | -35.94% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 13.55 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SGMOSangamo BioSciences ... | -0.03 | -0.38% |
| QLTIQLT Inc | +0.01 | +0.13% |
| IDIXIdenix Pharmaceutica... | +0.08 | +1.97% |
| AMRIAlbany Molecular Res... | +0.06 | +0.55% |
Data as of 4:00pm ET, 05/22/2013
Financials
| Next reporting date | August 28, 2013 |
| EPS forecast (this quarter) | -$0.20 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$39.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Gary S. Jacob, PhD |
Secretary & Senior Vice President Bernard F. Denoyer, MBA, CPA |
Corporate headquarters New York, New York |
Forecasts
